Theravance (THRX) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts THRX Hot Sheet
Price: $4.06 --0%
Financial Fact:
Research and development: 286K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Research and development: 286K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Theravance (NASDAQ: THRX) reported Q2 EPS of ($0.34), $0.01 better than the analyst estimate of ($0.35).
For earnings history and earnings-related data on Theravance (THRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
- Star Equity Holdings (STRR) Misses Q2 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
